Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
32.84
+0.98 (3.08%)
Aug 21, 2026, 10:12 AM EDT - Market open
Hims & Hers Health Market Cap
Hims & Hers Health has a market cap or net worth of $7.66 billion as of August 21, 2026. Its market cap has decreased by -21.85% in one year.
Market Cap
7.66B
Enterprise Value
8.37B
1-Year Change
-21.85%
Ranking
Category
Stock Price
$32.84
ChartMarket Cap Chart
Since September 13, 2019, Hims & Hers Health's market cap has increased from $246.53M to $7.66B, an increase of 3,007.93%. That is a compound annual growth rate of 64.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 7.66B | 3.66% |
| Dec 31, 2025 | 7.39B | 39.92% |
| Dec 31, 2024 | 5.28B | 180.00% |
| Dec 29, 2023 | 1.89B | 41.69% |
| Dec 30, 2022 | 1.33B | -0.30% |
| Dec 31, 2021 | 1.34B | 263.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurocrine Biosciences | 15.81B |
| Elanco Animal Health | 12.24B |
| Dr. Reddy's Laboratories | 10.21B |
| Alkermes | 8.42B |
| Liquidia | 6.74B |
| Lantheus Holdings | 6.56B |
| Kiniksa Pharmaceuticals International, | 6.30B |
| Amneal Pharmaceuticals | 5.78B |